Transgene: Combined General Meeting of May 26, 2021
26 Maggio 2021 - 5:45PM
Business Wire
Regulatory News:
The Combined Ordinary and Extraordinary General Meeting of
Transgene’s (Paris:TNG) shareholders was held today (May 26, 2021)
at 10:00 a.m. at the Company's headquarters (400 boulevard Gonthier
d'Andernach - Parc d'Innovation - 67400 Illkirch-Graffenstaden -
France) chaired by Hedi Ben Brahim, Chairman and CEO, to approve
the Company’s financial statements for the year ended December 31,
2020 and to vote the other resolutions submitted to their approval.
As a result of restrictions placed on the movement and gatherings
of persons in the context of the COVID-19 pandemic, this General
Meeting was held behind closed doors without the physical presence
of its shareholders. Its replay is available via Transgene’s
website and here.
At the Combined General Meeting, the shareholders adopted all
resolutions recommended for approval by the Board of Directors.
Detailed voting results are available on Transgene's website,
under the heading Investors > General Meeting.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210526005807/en/
Transgene:
Lucie Larguier Director Corporate Communications & IR
+33 (0)3 88 27 91 04 investorrelations@transgene.fr
Media:
Citigate Dewe Rogerson David Dible/Sylvie Berrebi + 44
(0)20 7638 9571 transgene@citigatedewerogerson.com
Grafico Azioni Transgene (EU:TNG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Transgene (EU:TNG)
Storico
Da Apr 2023 a Apr 2024
